These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The challenge of viral reservoirs in HIV-1 infection. Blankson JN; Persaud D; Siliciano RF Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490 [TBL] [Abstract][Full Text] [Related]
5. Cell and gene therapy strategies to eradicate HIV reservoirs. Spragg C; De Silva Feelixge H; Jerome KR Curr Opin HIV AIDS; 2016 Jul; 11(4):442-9. PubMed ID: 27031009 [TBL] [Abstract][Full Text] [Related]
6. Challenges and strategies for the eradication of the HIV reservoir. Kimata JT; Rice AP; Wang J Curr Opin Immunol; 2016 Oct; 42():65-70. PubMed ID: 27288651 [TBL] [Abstract][Full Text] [Related]
7. Immunological strategies to target HIV persistence. Martrus G; Altfeld M Curr Opin HIV AIDS; 2016 Jul; 11(4):402-8. PubMed ID: 27054281 [TBL] [Abstract][Full Text] [Related]
8. Tissue reservoirs of HIV. Wong JK; Yukl SA Curr Opin HIV AIDS; 2016 Jul; 11(4):362-70. PubMed ID: 27259045 [TBL] [Abstract][Full Text] [Related]
9. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors. Banga R; Procopio FA; Cavassini M; Perreau M J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693 [TBL] [Abstract][Full Text] [Related]
10. Impact of Myeloid Reservoirs in HIV Cure Trials. Mitchell BI; Laws EI; Ndhlovu LC Curr HIV/AIDS Rep; 2019 Apr; 16(2):129-140. PubMed ID: 30835045 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of HIV persistence in HIV reservoirs. Mzingwane ML; Tiemessen CT Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 28128885 [TBL] [Abstract][Full Text] [Related]
12. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy. Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043 [TBL] [Abstract][Full Text] [Related]
13. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy. Saksena NK; Potter SJ AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103 [TBL] [Abstract][Full Text] [Related]
14. Are T cells the only HIV-1 reservoir? Kandathil AJ; Sugawara S; Balagopal A Retrovirology; 2016 Dec; 13(1):86. PubMed ID: 27998285 [TBL] [Abstract][Full Text] [Related]
15. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection. Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407 [TBL] [Abstract][Full Text] [Related]
16. Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? Abbas W; Tariq M; Iqbal M; Kumar A; Herbein G Viruses; 2015 Mar; 7(4):1578-98. PubMed ID: 25835530 [TBL] [Abstract][Full Text] [Related]
17. A reservoir for HIV in patients on combination antiretroviral therapy. Siliciano RF Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130 [TBL] [Abstract][Full Text] [Related]
18. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578 [TBL] [Abstract][Full Text] [Related]
19. Strategies to target HIV-1 in the central nervous system. Gray LR; Brew BJ; Churchill MJ Curr Opin HIV AIDS; 2016 Jul; 11(4):371-5. PubMed ID: 26945147 [TBL] [Abstract][Full Text] [Related]
20. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Siliciano JD; Siliciano RF Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]